PNC Financial Services Group
TTPH

PNC Financial Services Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

PNC Financial Services Group’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11
Closed – – 4226
2019
Q1 		$0 Hold
11
– – ﹤0.01% 4200
2018
Q4 		$0 Sell
11
-10
-48% -$391 ﹤0.01% 4257
2018
Q3 		$2K Hold
21
– – ﹤0.01% 3995
2018
Q2 		$2K Hold
21
– – ﹤0.01% 4018
2018
Q1 		$2K Buy
21
+3
+17% +$263 ﹤0.01% 4083
2017
Q4 		$2K Buy
18
+8
+80% +$1.02K ﹤0.01% 4044
2017
Q3 		$2K Hold
10
– – ﹤0.01% 4047
2017
Q2 		$2K Hold
10
– – ﹤0.01% 4034
2017
Q1 		$2K Hold
10
– – ﹤0.01% 3989
2016
Q4 		$0 Sell
10
-15
-60% -$1.19K ﹤0.01% 4149
2016
Q3 		$1K Hold
25
– – ﹤0.01% 3922
2016
Q2 		$1K Hold
25
– – ﹤0.01% 4430
2016
Q1 		$1K Hold
25
– – ﹤0.01% 4432
2015
Q4 		$5K Buy
+25
New +$4.99K ﹤0.01% 3896
2015
Q3 		– Sell
-25
Closed -$24K – 4750
2015
Q2 		$24K Buy
+25
New +$20.4K ﹤0.01% 3428

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PNC Financial Services Group's TTPH Position: Q2 2019 in Review

PNC Financial Services Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 11 shares.

PNC Financial Services Group first reported a position in TTPH in Q2 2015 and held it in 15 quarters. The position peaked at $24K in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • PNC Financial Services Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • PNC Financial Services Group sold 11 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019.
  • PNC Financial Services Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2015 and held it in 15 quarters.
  • PNC Financial Services Group's Tetraphase Pharmaceuticals, Inc. position peaked at $24K in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on PNC Financial Services Group's 13F filing for Q2 2019, filed 9 Aug 2019.